Pfizer Archives - Health Issues India

FDA approves RSV maternal vaccine; The latest health stories from around the world

Leave a Comment / Covid-19, Featured, Featured Story, Infectious diseases, International, Medicine and Research, News, Newsletter / By Lalita Panicker

The U.S. Food and Drug Administration (FDA) has approved a vaccine given to pregnant women to protect babies from respiratory syncytial virus (RSV). The virus causes severe lung infections that are the leading cause of U.S. infant hospitalizations. https://www.science.org/content/article/rsv-vaccine-scientific-advisory-panels-and-biodiversity-hot-spot-risk? Pregnant people who receive the vaccine, called Abrysvo and made by Pfizer, can pass protective antibodies …

FDA approves RSV maternal vaccine; The latest health stories from around the world Read More »

New COVID-19 vaccine to be made available next month; The latest health stories from around the world

Leave a Comment / Access to Healthcare, Covid-19, Featured, Featured Story, Infectious diseases, International, Medicine and Research, News, Newsletter / By Lalita Panicker

A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly received even as hospitalizations from “Eris”, a variant of the Omicron form of the coronavirus, rise around the country. https://www.reuters.com/business/healthcare-pharmaceuticals/new-covid-vaccines-are-way-eris-variant-rises-2023-08-14/ Fortunately, early data suggests that the new shots will still be effective against Eris. …

New COVID-19 vaccine to be made available next month; The latest health stories from around the world Read More »

Long COVID symptoms identified by study; The latest health stories from around the world

Leave a Comment / Uncategorized / By Lalita Panicker

A team of scientists says it has nailed down the major symptoms of Long Covid, which has disabled millions of people since the pandemic began. https://www.science.org/content/article/major-u-s-effort-pins-down-symptoms-long-covid? In a study published yesterday (25 May) in The Journal of the American Medical Association, the researchers identified 12 key symptoms of the condition, including brain fog, post exertional …

Long COVID symptoms identified by study; The latest health stories from around the world Read More »

FDA approves new RSV vaccine; The latest health stories from around the world

Leave a Comment / Access to Healthcare, Covid-19, Featured, Featured Story, Infectious diseases, International, Medicine and Research, News, Newsletter / By Lalita Panicker

A panel advising the U.S. Food and Drug Administration (FDA) last week recommended that it approve a vaccine given to pregnant people to protect infants from respiratory syncytial virus (RSV), which can cause severe lung infections. https://www.science.org/content/article/news-glance-china-s-ethics-oversight-arpa-h-s-new-science-and-210-million-protein? The vote was unanimous based on the efficacy of the vaccine, called RSVpreF and branded Abrysvo. Ten members …

FDA approves new RSV vaccine; The latest health stories from around the world Read More »

Pfizer announces promising results for RSV vaccine

Leave a Comment / Featured, Infectious diseases, International, Medicine and Research, News, Newsletter / By Editor, Health Issues

Barney Graham, a former scientist at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), was thrilled when Pfizer announced encouraging results from an experimental vaccine that could protect against a major childhood killer. In a press release, the company said immunizing pregnant women with its vaccine against respiratory syncytial virus (RSV) protected their babies from severe …

Pfizer announces promising results for RSV vaccine Read More »

Pfizer set to test new COVID-19 pill on long-covid patients

Leave a Comment / Featured, Infectious diseases, Medicine and Research, News, Newsletter / By Editor, Health Issues

Plans for the first test of whether Pfizer’s COVID-19 pill known as Paxlovid can alleviate Long Covid were unveiled last week, as organizers said they expect to begin recruiting 1700 volunteers in January 2023. Patient groups and researchers have long sought such a trial to study whether suppressing the SARS-CoV-2 coronavirus can reduce Long COVID’s debilitating …

Pfizer set to test new COVID-19 pill on long-covid patients Read More »

Pfizer quadruples price of COVID-19 vaccines

Leave a Comment / Featured, Infectious diseases, International, News, Newsletter / By Editor, Health Issues

Pfizer’s plan to quadruple US prices for its COVID-19 vaccine next year is beyond Wall Street’s expectations and will spur its revenue for years despite weaker than anticipated demand for the new booster shot so far, analysts said. www.reuters.com/business/healthcare-pharmaceuticals/pfizer-covid-vaccine-price-hike-seen-giving-revenue-boost-years-2022-10-21/? The drugmaker, which developed and sells the vaccine with Germany’s BioNTech (22UAy.DE), said on Thursday evening …

Pfizer quadruples price of COVID-19 vaccines Read More »

Moderna sues rival Pfizer/BioNTech over patent violation of mRNA Covid vaccine

Leave a Comment / Featured, International, Medicine and Research / By Editor, Health Issues

The vaccine manufacturer Moderna has sued pharma major Pfizer and BioNTech, claiming that its rivals’ Covid-19 shot violates its patents protecting its ground-breaking technology www.nytimes.com/2022/08/26/business/moderna-covid-vaccine-lawsuit.html Moderna said in a statement that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 that covered its mRNA technology. Moderna, which is based in Cambridge, Mass., sued …

Moderna sues rival Pfizer/BioNTech over patent violation of mRNA Covid vaccine Read More »

Paxlovid appears to reduce the risk of dying from COVID-19 by 79% in those over 65

Leave a Comment / Featured Stories, International, Medicine and Research / By Editor, Health Issues

The antiviral drug Paxlovid appears to reduce the risk of dying from COVID-19 by 79% and decrease hospitalizations by 73% in at-risk patients aged 65 and older, according to a new study published in The New England Journal of Medicine. The pill, which is a combination of the drugs nirmatrelvir and ritonavir, received FDA emergency use authorization in …

Paxlovid appears to reduce the risk of dying from COVID-19 by 79% in those over 65 Read More »

Global heating will make you ill — just not how you think it will

Leave a Comment / Featured, Featured Story, Infectious diseases, News, Opinion / By Editor, Health Issues

Coming as it does at a time when COVID-19 resolutely refuses to pack up and go away, the 2021 United Nations Climate Change Conference (COP26) in Glasgow this November will likely discuss not only international climate action but the impact of climate on health issues as well. As the Lancet Countdown 2020 Report explained, no continent, country, or community is immune from …

Global heating will make you ill — just not how you think it will Read More »

Offer An Article

Pandemic Latest News

Pfizer

Long COVID symptoms identified by study; The latest health stories from around the world

Moderna sues rival Pfizer/BioNTech over patent violation of mRNA Covid vaccine

Paxlovid appears to reduce the risk of dying from COVID-19 by 79% in those over 65

Global heating will make you ill — just not how you think it will

About Us

Newsletter